Ferroptosis Activation Contributes to the Formation of Skin Lesions in Psoriasis Vulgaris
Antioxidants · 29.01.2023 · 12 (2) · 310
DOI: 10.3390/antiox12020310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 29.01.2023. Verfasst von Siying Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Key Laboratory of Medical Epigenomics, Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha 410011, Chi…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAMS Innovation Fund for Medical Sciences (CIFMS), Key project for international and regional cooperation in science and technology innovation of Hunan province, National Natural Science Foundation of China.
Abstract (Originalsprache)
(1)
Background
Ferroptosis is a newly coined form of programmed cell death marked by lethal accumulation of lipid peroxidation and ferrous iron overload. A few studies on the specific mechanism of ferroptosis in the genesis and development of psoriasis are available. (2)
Methods
Levels of lipid reactive oxygen species (ROS) and ferrous iron were measured by flow cytometry. Ultrastructure analysis was performed by transmission electron microscopy. Imiquimod-induced psoriasis-like mice were treated with a ferroptosis inducer. The expressions of mRNA of genes were measured by qRT-PCR. HaCaT cells were used to explore the function of Cyb561d2. (3)
Results
In this work, we observed that levels of lipid ROS and ferrous iron in the epidermis of psoriasis vulgaris (PV) patients were increased. The existence of ferroptosis activation in the epidermis of individuals with PV was confirmed by transmission electron microscope both in patients with PV and psoriasis-like mice models. Intradermal injection of the ferroptosis inducer RSL3 in psoriasis-like mice significantly promoted and aggravated the development of psoriasis-like dermatitis, and the level of serum transferrin was also increased in PV samples. Moreover, abnormal expression of some genes related to iron metabolism was also proved in the epidermis of PV cases, among which Cyb561d2 was shown to promote ferrous iron overload and lipid peroxidation accumulation in HaCaT cells. (4)
Conclusions
In summary, our study suggested that ferroptosis activation owing to iron overload may be a novel mechanism underlying the formation of skin lesions in individuals with PV.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hunan Key Laboratory of Medical Epigenomics, Department of Dermatology, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
- Research Unit of Key Technologies of Diagnosis and Treatment for Immune-Related Skin Diseases, Chinese Academy of Medical Sciences, Changsha 410011, China.
- Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha 410011, China.
Förderung
- CAMS Innovation Fund for Medical Sciences (CIFMS)
- Key project for international and regional cooperation in science and technology innovation of Hunan province
- National Natural Science Foundation of China
- the Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
Zitieren
APA
Li, S., Luo, X., Zhang, S., Su, Y., Deng, M., Zhu, Y., Zhang, P., Wu, R., & Zhao, M. (2023). Ferroptosis Activation Contributes to the Formation of Skin Lesions in Psoriasis Vulgaris. Antioxidants, 12(2), 310. https://doi.org/10.3390/antiox12020310
Vancouver
Li S, Luo X, Zhang S, Su Y, Deng M, Zhu Y, et al. Ferroptosis Activation Contributes to the Formation of Skin Lesions in Psoriasis Vulgaris. Antioxidants. 2023;12(2):310. doi:10.3390/antiox12020310
BibTeX
@article{Li2023,
author = {Li, Siying and Luo, Xin and Zhang, Suhan and Su, Yuwen and Deng, Min and Zhu, Yanshan and Zhang, Peng and Wu, Ruifang and Zhao, Ming},
title = {Ferroptosis Activation Contributes to the Formation of Skin Lesions in Psoriasis Vulgaris},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {2},
pages = {310},
doi = {10.3390/antiox12020310}
}
EUVIMED